Nu Skin Enterprises reported fourth quarter 2025 revenue of $370.3 million and diluted EPS of $0.29, both within guidance. The company achieved over 50% growth in earnings for the full year 2025, driven by effective margin improvement and cost optimization. Strategic initiatives like the global launch of Prysm iO and pre-market activities in India are expected to drive year-over-year revenue growth by the end of 2026.
Fourth quarter 2025 revenue was $370.3 million, a 16.9% decrease year-over-year, or 10.4% excluding Mavely 2024 revenue.
Diluted earnings per share for Q4 2025 was $0.29, compared to $(0.73) in the prior-year quarter, or $0.38 excluding restructuring and other charges.
Full-year 2025 revenue reached $1.49 billion, a 14.3% decrease, or 10.7% excluding Mavely 2024 revenue.
Full-year 2025 diluted EPS was $3.18, or $1.27 excluding Mavely gain and other charges, significantly up from $(2.95) in 2024.
Nu Skin Enterprises anticipates a return to year-over-year revenue growth by the end of 2026, with Q1 2026 revenue projected between $320 million and $340 million and full-year 2026 revenue between $1.35 billion and $1.50 billion. Diluted EPS for Q1 2026 is expected to be $0.10 to $0.20, and for the full year, $0.80 to $1.20.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance